TY - JOUR
T1 - TiO2 nanoparticles prepared without harmful organics: A biosafe and economical approach
AU - Shah, M.A.
AU - Al-Marzouki, F.M.
N1 - KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: We are thankful for the Deanship of Research Studies, KAU, for the financial support of this work. We are also thankful to KAUST, Jeddah and KACST, Riyadh, for the characterization of samples.
This publication acknowledges KAUST support, but has no KAUST affiliated authors.
PY - 2011/6
Y1 - 2011/6
N2 - Growth of titanium oxide (TiO2) nanoparticles of varying size, ranging from 20-60 nms through a versatile and an economic route, is being reported. The approach is based on a simple reaction of titanium powder and De-Ionized (DI) water at ∼180 °C, without use of any harmful additives. Field Emission Scanning Electron Microscopy (FESEM) reveals the well defined morphology of nanoparticles, whereas X-ray Diffraction (XRD) studies reveal that the, as prepared, nanoparticles are in a mixed phase, with a dominance of a stable rutile phase. Since only water, which is regarded as a benign solvent, is used during the preparation of nanoparticles, we believe that the products so produced are biocompatible and bio-safe and can be readily used for medical applications. The biocompatibility tests are yet to be carried out and shall be reported in forthcoming publications. © 2011 Sharif University of Technology. Production and hosting by Elsevier B.V. All rights reserved.
AB - Growth of titanium oxide (TiO2) nanoparticles of varying size, ranging from 20-60 nms through a versatile and an economic route, is being reported. The approach is based on a simple reaction of titanium powder and De-Ionized (DI) water at ∼180 °C, without use of any harmful additives. Field Emission Scanning Electron Microscopy (FESEM) reveals the well defined morphology of nanoparticles, whereas X-ray Diffraction (XRD) studies reveal that the, as prepared, nanoparticles are in a mixed phase, with a dominance of a stable rutile phase. Since only water, which is regarded as a benign solvent, is used during the preparation of nanoparticles, we believe that the products so produced are biocompatible and bio-safe and can be readily used for medical applications. The biocompatibility tests are yet to be carried out and shall be reported in forthcoming publications. © 2011 Sharif University of Technology. Production and hosting by Elsevier B.V. All rights reserved.
UR - http://hdl.handle.net/10754/600030
UR - https://linkinghub.elsevier.com/retrieve/pii/S1026309811001118
UR - http://www.scopus.com/inward/record.url?scp=80054909144&partnerID=8YFLogxK
U2 - 10.1016/j.scient.2011.06.006
DO - 10.1016/j.scient.2011.06.006
M3 - Article
SN - 1026-3098
VL - 18
SP - 804
EP - 807
JO - Scientia Iranica
JF - Scientia Iranica
IS - 3
ER -